Mirum Pharmaceuticals (NASDAQ: MIRM)
$23.57
(-1.2%)
-$0.28
Price as of April 18, 2024, 4:00 p.m. ET
Mirum Pharmaceuticals Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Mirum Pharmaceuticals Company Info
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its products include Maralixibat and Volixibat. The company was founded by Niall O'Donnel, Michael Grey and Christopher Peetz in May 2018 and is headquartered in Foster City, CA.
News & Analysis
Featured Article
Here's Why Mirum Pharmaceuticals Rocketed 240% in December
It appears the FDA is willing to work with Mirium to get maralixibat approved as quickly as possible.
Cory Renauer | Jan 5, 2020
Featured Article
Here's Why Mirum Pharmaceuticals' Stock Jumped in December
This newly public drug developer tripled its stock price in November following positive FDA news.
David Haen | Jan 2, 2020
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.